Inflammation is a major regulator of drug metabolizing enzymes and transporters: consequences for the personalization of drug treatment

F Stanke-Labesque, E Gautier-Veyret, S Chhun… - Pharmacology & …, 2020 - Elsevier
Inflammation is an evolutionary process that allows survival against acute infection or injury.
Inflammation is also a pathophysiological condition shared by numerous chronic diseases …

Human small intestinal organotypic culture model for drug permeation, inflammation, and toxicity assays

J Markus, T Landry, Z Stevens, H Scott… - In Vitro Cellular & …, 2021 - Springer
The gastrointestinal tract (GIT), in particular, the small intestine, plays a significant role in
food digestion, fluid and electrolyte transport, drug absorption and metabolism, and nutrient …

Recent Advances in Cell‐Based In Vitro Models to Recreate Human Intestinal Inflammation

MH Macedo, M Dias Neto, L Pastrana… - Advanced …, 2023 - Wiley Online Library
Inflammatory bowel disease causes a major burden to patients and healthcare systems,
raising the need to develop effective therapies. Technological advances in cell culture, allied …

Inflammation induces changes in the functional expression of P-gp, BCRP, and MRP2: an overview of different models and consequences for drug disposition

S Saib, X Delavenne - Pharmaceutics, 2021 - mdpi.com
The ATP-binding cassette (ABC) transporters play a key role in drug pharmacokinetics.
These membrane transporters expressed within physiological barriers can be a source of …

Assessment of CYP3A‐mediated drug interaction via cytokine (IL‐6) elevation for mosunetuzumab using physiologically‐based pharmacokinetic modeling

Y Chen, F Ma, N Jones, R Deng, C Li… - CPT: pharmacometrics …, 2024 - Wiley Online Library
Mosunetuzumab is a CD3/CD20 bispecific antibody. As an on‐target effect, transient
elevation of interleukin‐6 (IL‐6) occurs in early treatment cycles. A physiologically‐based …

Modeling Approach to Predict the Impact of Inflammation on the Pharmacokinetics of CYP2C19 and CYP3A4 Substrates

F Simon, E Gautier-Veyret, A Truffot, M Chenel… - Pharmaceutical …, 2021 - Springer
Purpose For decades, inflammation has been considered a cause of pharmacokinetic
variability, mainly in relation to the inhibitory effect of pro-inflammatory cytokines on the …

Cytotoxicity and Bioimmunological Activity of Poly (2-Isopropenyl-2-oxazoline) Conjugates with Ibuprofen Using 3D Reconstructed Tissue Models

Z Kroneková, M Majerčíková… - …, 2024 - ACS Publications
Poly (2-isopropenyl-2-oxazoline)(PIPOx) represents a universal polymer platform with
pendant 2-oxazoline groups, allowing the preparation of biomaterials for various biomedical …

The influences and mechanisms of high-altitude hypoxia exposure on drug metabolism

A Zhao, W Li, R Wang - Current Drug Metabolism, 2023 - ingentaconnect.com
Background: The special environment of high-altitude hypoxia not only changes the
physiological state of the body but also affects the metabolic process of many drugs, which …

CYP3A-status is associated with blood concentration and dose-requirement of tacrolimus in heart transplant recipients

M Déri, Z Szakál-Tóth, F Fekete, K Mangó, E Incze… - Scientific Reports, 2021 - nature.com
High inter-individual variability in tacrolimus clearance is attributed to genetic
polymorphisms of CYP3A enzymes. However, due to CYP3A phenoconversion induced by …

[HTML][HTML] SARS‐CoV‐2 infection increases tacrolimus concentrations in solid‐organ transplant recipients

DM Salerno, D Kovac, H Corbo, DL Jennings… - Clinical …, 2021 - ncbi.nlm.nih.gov
Calcineurin inhibitors (CNIs) are narrow therapeutic index medications, with drug
concentrations altered by factors such as drug-drug interactions, clinical symptoms including …